$306.50 +6.43 (%) Actavis PLC - NYSE

May. 27, 2015 | 03:50 PM

Partner Headlines

  1. 5 Drugs That Could Be Summer Blockbusters

    IBD | May. 26, 2015 | 08:02AM EST
  2. Skyworks, Avago Among IBD 50 Stocks You Need To Know

    IBD | May. 22, 2015 | 18:55PM EST
  3. Autobytel Boosts Guidance Significantly; Pershing Square Capital Sees Potential In Actavis

    GuruFocus | May. 22, 2015 | 17:30PM EST
  4. Valeant CEO: Healthcare Sector A 'Bit Of A Bubble'

    Benzinga | May. 22, 2015 | 10:34AM EST
  5. IBD Your Weekly Review: Techs, Health Care Still Lead

    IBD | May. 21, 2015 | 17:24PM EST
  6. 3 Top IBD 50 Stocks Hit New All-Time Highs

    IBD | May. 21, 2015 | 16:36PM EST
  7. Hedge Funds Bet Higher Oil; Long Apple, Short Intel

    IBD | May. 21, 2015 | 11:06AM EST
  8. Lee Ainslie Adds 90 New Stocks to His Portfolio Within the First Quarter

    GuruFocus | May. 20, 2015 | 14:16PM EST
  9. Bill Ackman Adds Two Positions to Portfolio in 1QFY15

    GuruFocus | May. 19, 2015 | 13:48PM EST
  10. Viking Global Liked AIG, Google, Actavis, Illumina And Cheniere Energy Last Quarter

    Benzinga | May. 18, 2015 | 13:38PM EST
  11. Synergy Rallies 18% Following News of Paulson & Co. Stake

    Benzinga | May. 18, 2015 | 10:10AM EST
  12. John Paulson Continues To Bet On Health Care And TV

    Benzinga | May. 17, 2015 | 10:49AM EST
  13. John Paulson Buys Actavis, AIG, Valeant, Sells Equinix, Alibaba

    GuruFocus | May. 16, 2015 | 19:49PM EST
  14. Bill Ackman's Latest Moves In Health Care & Some Other Positions From Q1

    Benzinga | May. 16, 2015 | 09:54AM EST
  15. Actavis Grows Through Aggressive Acquisitions

    IBD | May. 15, 2015 | 18:13PM EST
  16. Tiger Management Likes Chinese Tech Stocks, Cheniere Energy And Actavis

    Benzinga | May. 15, 2015 | 14:18PM EST
  17. Leon Cooperman's Omega Advisors Sells Apple, Gilead; Buys Humana, GM And IBM

    Benzinga | May. 15, 2015 | 12:11PM EST
  18. Canaccord On Actavis: 'Consensus Isn't Always Wrong'

    Benzinga | May. 12, 2015 | 16:41PM EST
  19. Leerink Is Changing Targets At These 7 Biotechs

    Benzinga | May. 12, 2015 | 12:54PM EST
  20. Actavis, Ligand Top Q1 Views

    IBD | May. 11, 2015 | 18:46PM EST
  21. Actavis Offers Post-Allergan Guidance; Ligand Jumps

    IBD | May. 11, 2015 | 18:36PM EST
  22. Actavis Q1 Beats Estimates, Includes Allergan In 2015 Guidance

    IBD | May. 11, 2015 | 10:59AM EST
  23. Stocks Start Week Quiet And Mixed; Monster, Cisco, Dean Foods Advance

    IBD | May. 11, 2015 | 10:35AM EST
  24. Morning Market Gainers

    Benzinga | May. 11, 2015 | 09:48AM EST
  25. Stock Futures Narrowly Lower; Actavis, AerCap Holdings Jump

    IBD | May. 11, 2015 | 09:05AM EST
  26. Benzinga's Top #PreMarket Gainers

    Benzinga | May. 11, 2015 | 08:25AM EST
  27. US Stock Futures Edge Higher

    Benzinga | May. 11, 2015 | 07:54AM EST
  28. Actavis Beats Q1 Expectations, Shares Jump

    Benzinga | May. 11, 2015 | 07:36AM EST
  29. Earnings Scheduled For May 11, 2015

    Benzinga | May. 11, 2015 | 04:04AM EST
  30. Actavis Earnings On Tap After 3 Other IBD 50 Stocks

    IBD | May. 9, 2015 | 08:02AM EST
  31. Dow Leads Market Gains; NYSE Winners Top Losers 4-1

    IBD | May. 8, 2015 | 16:57PM EST
  32. Sucampo Stock Rebounds As Drug Gets Fast-Track Review

    IBD | May. 8, 2015 | 11:11AM EST
  33. Barclays Hopes Pulmicort Is 'Back For Good' At Actavis

    Benzinga | May. 8, 2015 | 10:22AM EST
  34. Mizuho Gives Actavis Buy Rating Following AGN Acquisition Close

    Benzinga | May. 8, 2015 | 07:21AM EST
  35. Many Leaders Forming Bases As Market Correction Takes Hold

    IBD | May. 7, 2015 | 18:05PM EST
  36. Leading Stock Mallinckrodt Delivers Strong Results As Base Forms

    IBD | May. 6, 2015 | 18:13PM EST
  37. RBC Capital's Top 20 U.S. Stock Picks

    Benzinga | May. 4, 2015 | 12:48PM EST
  38. Is The Drug Industry's Wedding Dance Nearly Finished?

    IBD | May. 1, 2015 | 16:08PM EST
  39. Viking Global's Shareholder Letter Talks New Positions In Google, Cheniere, Biggest Winners & Losers

    Benzinga | May. 1, 2015 | 12:15PM EST
  40. Valeant Beats Q1 Views, Lifts Guidance, Loses CFO

    IBD | Apr. 29, 2015 | 17:13PM EST
  41. Valeant Beats Q1 Views, Lifts Guidance, But Loses CFO

    IBD | Apr. 29, 2015 | 10:55AM EST
  42. Actavis, Medicines360 Report Publication of ACCESS IUS Efficacy, Safety Study of LILETTA

    Benzinga | Apr. 28, 2015 | 16:18PM EST
  43. Global Worries Sink U.S. Stocks; Apple Breaches Support Level

    IBD | Apr. 17, 2015 | 16:37PM EST
  44. How To Buy A Rising Market Leader On A Pullback

    IBD | Apr. 14, 2015 | 17:03PM EST
  45. Andreas Halvorsen Keeps Buying DVA, HLT, ACT

    GuruFocus | Apr. 10, 2015 | 22:26PM EST
  46. Actavis contraceptive OK'd

    IBD | Feb. 27, 2015 | 18:50PM EST
  47. Meet IBD's 4 A Stocks With Rising Earnings Estimates

    IBD | Feb. 27, 2015 | 16:27PM EST
  48. Meet IBD's 4 A Stocks With Rising Earnings Estimates

    IBD | Feb. 26, 2015 | 19:47PM EST
  49. Biotech Pharmacyclics Spikes On Buyout Rumors

    IBD | Feb. 25, 2015 | 14:31PM EST
  50. Stock Chart Skills: The Beauty Of A Symmetrical Base

    IBD | Feb. 24, 2015 | 17:22PM EST
Trading Center